𝔖 Bobbio Scriptorium

✦ LIBER ✦

Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis

✍ Scribed by Kimball, Alexa B.

Book ID: 118252785
Publisher: American Medical Association
Year: 2008
Tongue: English
Weight: 157 KB
Volume: 144
Category: Article
ISSN: 0003-987X
DOI: 10.1001/archdermatol.2007.63

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment efficacy and long-term safet

Retreatment efficacy and long-term safety of the fully human, interleukin -12/-23 monoclonal antibody ABT-874 in the treatment of moderate to severe psoriasis: 48-week results from a phase II trial

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficacy and safety results of ABT-874 v

Efficacy and safety results of ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Efficacy and safety results of secukinum

Efficacy and safety results of secukinumab, a fully human monoclonal anti-interleukin-17a antibody, in the treatment of moderate-to-severe plaque psoriasis: A phase II regimen-finding trial

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficacy and safety of ABT-874, a monocl

Efficacy and safety of ABT-874, a monoclonal anti–interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial

✍ Alexa B. Kimball; Kenneth B. Gordon; Richard G. Langley; Alan Menter; Renee J. P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 620 KB

Long-term safety and efficacy of adalimu

Long-term safety and efficacy of adalimumab in the treatment of moderate to severe chronic plaque psoriasis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A multiple dose randomized double-blind

A multiple dose randomized double-blind placebo-controlled study to determine the efficacy and safety of a humanized anti-CD4 monoclonal antibody in the treatment of moderate to severe chronic psoriasis vulgaris

✍ Gottlieb, AB; Krueger, J; Lebwohl, M; Gisoldi, E; Grossman, RM; Wacholtz, MC 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 190 KB